US Patent Issued to Deciphera Pharmaceuticals on April 29 for "Methods of treating disorders using CSF1R inhibitors" (Massachusetts Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,285,430, issued on April 29, was assigned to Deciphera Pharmaceuticals LLC (Waltham, Mass.).

"Methods of treating disorders using CSF1R inhibitors" was invented by Daniel L. Flynn (Waltham, Mass.), Bryan D. Smith (Waltham, Mass.), Rodrigo Ruiz Soto (Waltham, Mass.) and Keisuke Kuida (Waltham, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are methods of treating cancers and other tumors related to the decreased proliferation, the depletion, or the repolarization of tumor-associated macrophages (TAMs) and treatment of associated disorders, including tenosynovial giant cell tumor (TGCT) and diffuse-type tenosynovial giant cell tumor ...